Insight Molecular Diagnostics Inc. - Common Stock, no par value (IMDX)

CUSIP: 68235C206

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 5 signals
Share change
-64,860
SEC-reported price per share
$5.89
Number of holders
2
Value change
-$382,635
Number of sells
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
32,330,312

Security key

68235C206

Report period

Q2 2026

Institutions

2

Top holders

2

Ownership snapshot

Top reported holders of IMDX - Insight Molecular Diagnostics Inc. - Common Stock, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BROADWOOD PARTNERS, L.P.
Disclosed value leader
BROADWOOD PARTNERS, L.P.
Comparable rows
15/15
Latest evidence
23 Apr 2026
3/4/5 13D/G 13F Lead comparable stake: 40% 13D/G row: BROADWOOD PARTNERS, L.P. Showing 1-6 of 15 holder rows.

Quick read

BROADWOOD PARTNERS, L.P. leads the comparable SEC ownership view at 40%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BROADWOOD PARTNERS, L.P.'s linked filing trail.
Comparable ownership Top 5
BROADWOOD PARTNERS, L.P. 40%
Patrick W. Smith 10%
AWM Investment Company, Inc. 10%
BIO-RAD LABORATORIES, INC. 9.7%
BROADWOOD CAPITAL INC 37%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BROADWOOD PARTNERS, L.P.
3/4/5 13D/G
10%+ Owner · Neal C. Bradsher
40%
from 13D/G
$88,478,605
25,669,954 shares
mixed-class rows
+$5,685,126 23 Apr 2026
Patrick W. Smith
3/4/5 13D/G
10%+ Owner
10%
from 13D/G
$6,679,894
3,258,485 shares
07 Feb 2025
AWM Investment Company, Inc.
13D/G 13F
Company
10%
$9,685,464
2,857,069 shares
+$5,257,076 31 Mar 2025
BIO-RAD LABORATORIES, INC.
13D/G
9.7%
$608,097
2,764,078 shares
$0 10 Feb 2025
BROADWOOD CAPITAL INC
3/4/5 13F
10%+ Owner · Company
37%
from 13F
$88,478,605
25,669,954 shares
mixed-class rows
+$2,685,127 23 Apr 2026
PURA VIDA INVESTMENTS, LLC
13F 3/4/5
Company · 10%+ Owner
2.9%
$3,106,600
947,134 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
2
Shares
182,586
Rows available
2
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
41
Q2 2026 holders
2
Holder diff
-39
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .